World Scientific Annual Review of Cancer Immunology (WSARCI)

The World Scientific Annual Review of Cancer Immunology (WSARCI) is a unique journal that serves as a forum for clinicians and scientists to publish their work across the field of immuno-oncology. WSARCI aims to serve the community by publishing basic, translational, and clinical research that progresses the field of cancer immunology. Cancer care and research in Asia faces unique challenges in contrast to other global regions, in various perspectives such as disease subtypes (Asian cancers), access to technologies, and socio-economic issues. The differences are magnified in the new era of immunotherapy and cell therapy, as well as by the emergence of new technologies in diagnostics and research. Furthermore, it is also widely reported that cancers in Asia harbor unique biology; molecularly and immunologically.

World Scientific Annual Review of Cancer Immunology (WSARCI) is :-

• International, Peer-Reviewed, Open Access, Refereed, Immuno-oncology, Cancer immunology, Immunopathology, Immunoinformatic, Economics research, Artificial intelligence , Online or Print , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2972-3892, E-ISSN: 2972-3906, Established: 2024,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE